COM:CRINETICS
Crinetics Pharmaceuticals
- Stock
Last Close
57.03
22/11 21:00
Market Cap
4.01B
Beta: -
Volume Today
1.02M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.05 - | 0.13 180.44% | 0.01 89.20% | 0.01 35.40% | 0.00 95.77% | 0.00 693.49% | 0.01 337.98% | 0.01 53.04% | |
cash conversion cycle | -1.33K - | ||||||||
cash per share | 0.88 - | 1.02 16.79% | 13.50 1,219.81% | 4.90 63.71% | 5.61 14.60% | 8.68 54.70% | 6.43 25.90% | 9.62 49.51% | |
company equity multiplier | -2.03 - | -1.04 48.87% | -3.95 280.56% | -1.39 64.83% | -1.09 21.26% | -1.28 16.52% | -0.80 37.12% | 1.18 246.97% | |
days of inventory outstanding | |||||||||
days of payables outstanding | 2.18K - | ||||||||
days of sales outstanding | 44.62 - | 131.01 193.62% | 238.12 81.76% | 421.60 77.05% | 9.42K 2,135.09% | 687.00 92.71% | 186.85 72.80% | 850.51 355.18% | |
dividend yield | |||||||||
ebit per revenue | -10.26 - | -4.46 56.51% | -11.82 164.94% | -45.12 281.61% | -1.06K 2,239.54% | -99.91 90.54% | -35.44 64.53% | -55.47 56.52% | |
ebt per ebit | 1.00 - | 1.00 0.75% | 0.94 5.86% | 0.94 0.82% | 0.98 5.14% | 1.00 1.49% | 0.98 2.31% | 0.96 1.30% | |
effective tax rate | -0.00 - | 0.00 362.92% | -0.06 1,446.62% | 0.02 129.91% | 0.01 26.99% | 0.01 33.31% | 0.02 182.33% | ||
enterprise value multiple | -55.48 - | -36.13 34.87% | -11.12 69.23% | -10.61 4.57% | -4.54 57.17% | -8.30 82.76% | -5.48 33.96% | -9.31 69.84% | |
fixed asset turnover | 2.63 - | 5.11 94.43% | 0.57 88.78% | 0.18 67.79% | 0.01 92.90% | 0.23 1,642.34% | 0.95 315.72% | 0.07 92.65% | |
free cash flow per share | -0.41 - | -0.70 72.91% | -1.69 139.72% | -1.94 14.74% | -2.04 5.38% | -2.32 13.36% | -2.25 2.94% | -2.94 30.98% | |
gross profit margin | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 0.73 27.36% | |
interest coverage | -549.45 - | -1.14K 107.64% | -38.89 - | ||||||
inventory turnover | |||||||||
long term debt to capitalization | -0.03 - | -0.05 - | -0.02 54.99% | -0.01 53.97% | -0.00 59.00% | 0.08 1,850.77% | |||
net income per ebt | 1 - | 1 0% | 1 0% | 0.98 1.76% | 0.99 0.48% | 0.99 0.43% | 0.98 1.58% | 1 2.48% | |
net profit margin | -10.22 - | -4.48 56.18% | -11.17 149.40% | -41.52 271.80% | -1.03K 2,371.63% | -99.00 90.35% | -33.77 65.89% | -53.46 58.32% | |
operating cash flow per share | -0.39 - | -0.68 73.35% | -1.60 134.64% | -1.92 19.71% | -2.04 6.18% | -2.30 13.14% | -2.22 3.84% | -2.86 29.22% | |
operating cycle | 850.51 - | ||||||||
operating profit margin | -10.26 - | -4.46 56.51% | -11.82 164.94% | -45.12 281.61% | -1.06K 2,239.54% | -99.91 90.54% | -35.44 64.53% | -55.47 56.52% | |
payables turnover | 0.17 - | ||||||||
pretax profit margin | -10.22 - | -4.48 56.18% | -11.17 149.40% | -42.26 278.46% | -1.04K 2,359.74% | -99.85 90.40% | -34.60 65.35% | -53.46 54.49% | |
price fair value | -54.83 - | -22.64 58.70% | -8.39 62.93% | -6.47 22.97% | -2.56 60.36% | -3.97 54.77% | -2.17 45.40% | 3.83 276.94% | |
receivables turnover | 8.18 - | 2.79 65.94% | 1.53 44.98% | 0.87 43.52% | 0.04 95.53% | 0.53 1,271.64% | 1.95 267.67% | 0.43 78.03% | |
return on assets | -0.48 - | -0.59 22.88% | -0.16 73.06% | -0.38 140.19% | -0.40 4.54% | -0.30 23.46% | -0.45 49.39% | -0.34 25.66% | |
return on capital employed | -0.52 - | -0.62 20.28% | -0.18 71.71% | -0.44 151.19% | -0.43 1.76% | -0.32 25.82% | -0.52 60.95% | -0.38 27.26% | |
return on equity | 0.97 - | 0.61 37.17% | 0.63 2.54% | 0.53 15.51% | 0.43 17.68% | 0.39 10.81% | 0.36 6.06% | -0.40 209.26% | |
total debt to capitalization | -0.04 - | -0.05 - | -0.02 54.99% | -0.01 53.97% | -0.00 59.00% | 0.09 1,990.95% |
All numbers in USD (except ratios and percentages)